Mr Anthony Radford was a member of the CSIRO team that invented the QuantiFERON method for Cellular Immune based diagnostics. He later joined Amrad in pharmaceutical research and was Head of Development in 2000. Establishing offices and operations in the USA, Europe and Japan, Cellestis developed QuantiFERON TB Gold, the worldwide benchmark for diagnosis of tuberculosis infection. Dr. Radford was CEO of Cellestis from founding until its acquisition by QIAGEN NV in 2011.He is a Fellow of the Australian Academy of Technology and Engineering, and a recipient of their Clunies Ross Prize.He is member of Risk Committee.
